Prostate Cancer News on BioPortfolio

OncBioMune submits protocol for Phase ll trial of ProscaVax

OncBioMune Pharmaceuticals has submitted the protocol for a proposed Phase II clinical trial of ProscaVax vaccine for advanced prostate cancer...Read More...The post OncBioMune submits protocol for Phase ll trial of ProscaVax appeared first on Drug Develop...

Glutamate Carboxypeptidase 2 Folate Hydrolase 1 or Prostate Specific Membrane Antigen or PSMA or Pteroylpoly Gamma Glutamate Carboxypeptidase or Cell Growth Inhibiting Gene 27 Protein or FOLH1 or EC 3.4.17.21 Pipeline Review H2 2018 Report Updated 210

Glutamate Carboxypeptidase 2 Folate Hydrolase 1 or Prostate Specific Membrane Antigen or PSMA or Pteroylpoly Gamma Glutamate Carboxypeptidase or Cell Growth Inhibiting Gene 27 Protein or FOLH1 or EC 3.4.17.21 Pipeline Review H2 2018SummaryAccording to the...

Pages